Evidence map›Paper›PMID 25453189›Full record

ArticleCell metabolism2014

The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo.

Brandon L Panaro, Iain R Tough, Maja S Engelstoft, Robert T Matthews, Gregory J Digby, Cathrine L Møller, Berit Svendsen, Fiona Gribble, Frank Reimann, Jens J Holst and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 1 synthesis or guideline pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2025
    Article
  18. Article
  19. Review
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Brandon L PanaroDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Iain R ToughKing's College London, Wolfson Centre for Age-Related Diseases, Guy's Campus, London SE1 1UL, UK.
Maja S EngelstoftNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Medical and Health Sciences, University of Copenhagen, 2200 Denmark; Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Medical and Health Sciences, University of Copenhagen, 2200 Denmark; Danish Diabetes Academy, 5000 Odense, Denmark.
Robert T MatthewsDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Gregory J DigbyDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Cathrine L MøllerNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Medical and Health Sciences, University of Copenhagen, 2200 Denmark; Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Medical and Health Sciences, University of Copenhagen, 2200 Denmark; Diabetes and Obesity Biology, Novo Nordisk A/S, 2760 Maaloev, Denmark.
Berit SvendsenNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Medical and Health Sciences, University of Copenhagen, 2200 Denmark; Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, 2200 Denmark.
Fiona GribbleUniversity of Cambridge, Cambridge Institute for Medical Research (CIMR) & MRC Metabolic Diseases Unit (MDU), Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.
Frank ReimannUniversity of Cambridge, Cambridge Institute for Medical Research (CIMR) & MRC Metabolic Diseases Unit (MDU), Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.
Jens J HolstNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Medical and Health Sciences, University of Copenhagen, 2200 Denmark; Danish Diabetes Academy, 5000 Odense, Denmark.
Birgitte HolstNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Medical and Health Sciences, University of Copenhagen, 2200 Denmark; Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Medical and Health Sciences, University of Copenhagen, 2200 Denmark.
Thue W SchwartzNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Medical and Health Sciences, University of Copenhagen, 2200 Denmark; Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Medical and Health Sciences, University of Copenhagen, 2200 Denmark.
Helen M CoxKing's College London, Wolfson Centre for Age-Related Diseases, Guy's Campus, London SE1 1UL, UK.
Roger D ConeDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. Electronic address: roger.cone@vanderbilt.edu.
Novo Nordisk Foundation · DKVanderbilt University · USKing's College London · GBUniversity of Cambridge · GBUniversity of Copenhagen · DK

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
Melanocortin Signaling in Feeding BehaviorR01DK070332 · NIDDK · VANDERBILT UNIVERSITY · PI CONE, ROGER D. · 2004 to 2017
$6.1M
Molecular and Cellular Basis for the Efficacy of Bariatric SurgeryR24DK096527 · NIDDK · VANDERBILT UNIVERSITY · PI ABUMRAD, NAJI N, CONE, ROGER D. · 2013 to 2014
$1.2M
Medical Research Council MC_UU_12012/3NIDDK NIH HHS DK20593NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS P30DK058404NIDDK NIH HHS R01 DK070332NIDDK NIH HHS R01DK070332NIDDK NIH HHS R24 DK096527NIDDK NIH HHS R24DK096527Wellcome Trust 088357Wellcome Trust 100574Wellcome Trust WT084210/Z/07/ZWellcome Trust WT088357/Z/09/Z
6 · The paper itself

Abstract

The melanocortin-4 receptor (MC4R) is expressed in the brainstem and vagal afferent nerves and regulates a number of aspects of gastrointestinal function. Here we show that the receptor is also diffusely expressed in cells of the gastrointestinal system, from stomach to descending colon. Furthermore, MC4R is the second most highly enriched GPCR in peptide YY (PYY) and glucagon-like peptide 1 (GLP-1) expressing enteroendocrine L cells. When vectorial ion transport is measured across mouse or human intestinal mucosa, administration of α-MSH induces a MC4R-specific PYY-dependent antisecretory response consistent with a role for the MC4R in paracrine inhibition of electrolyte secretion. Finally, MC4R-dependent acute PYY and GLP-1 release from L cells can be stimulated in vivo by intraperitoneal (i.p.) administration of melanocortin peptides to mice. This suggests physiological significance for MC4R in L cells and indicates a previously unrecognized peripheral role for the MC4R, complementing vagal and central receptor functions.

Indexed as

Acids, HeterocyclicAnimalsColonEnteroendocrine CellsGlucagon-Like Peptide 1HumansImmunohistochemistryMiceMice, Inbred C57BLMice, TransgenicOxadiazolesPeptides, CyclicPeptide YYReceptor, Melanocortin, Type 4Acids, HeterocyclicGlucagon-Like Peptide 1HS014 cyclic peptideOxadiazolesPeptides, CyclicPeptide YYPSN 632408Receptor, Melanocortin, Type 4

Identifiers

PMID25453189
PMCPMC4255280
OpenAlexW2161888764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.